What do we do?

Our research explores how aging and cancer therapy disturb the body’s metabolic supply chains, creating local scarcities that shift the fitness landscape within tissues. These metabolic bottlenecks weaken normal cells — including immune cells — while giving precancerous clones a competitive edge. In ecological terms, the environment changes before the species do. By understanding and reprogramming these environmental shifts, we aim to prevent cancer, enhance therapy response, and promote healthier survivorship.